Back to top
more

Arrowhead Pharmaceuticals (ARWR)

(Real Time Quote from BATS)

$25.13 USD

25.13
43,405

+0.46 (1.87%)

Updated May 24, 2024 10:28 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.08%
2Buy17.91%
3Hold9.44%
4Sell5.10%
5Strong Sell2.55%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 36% (90 out of 249)

Industry: Medical - Drugs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Brokerage Reports

0 items in cart

Arrowhead Pharmaceuticals, Inc. [ARWR]

Reports for Purchase

Showing records 21 - 40 ( 90 total )

Company: Arrowhead Pharmaceuticals, Inc.

Industry: Medical - Drugs

Record: 21

05/18/2022

Company Report

Pages: 10

F2Q22 Results; Pulmonary R&D Day Expected May 26; Alpha One Updates Expected Near-Term; CVD Programs on Track

Provider: H.C. Wainwright & Co., Inc.

Analyst: TRUCCHIO P

Price: 12.50

Research Provided by a Third Party

Company: Arrowhead Pharmaceuticals, Inc.

Industry: Medical - Drugs

Record: 22

03/23/2022

Company Report

Pages: 8

HCW "At Home" Recap: Reiterate Buy Ahead of Plethora of Data Updates on Broad RNAi Therapeutics Pipeline

Provider: H.C. Wainwright & Co., Inc.

Analyst: TRUCCHIO P

Price: 12.50

Research Provided by a Third Party

Company: Arrowhead Pharmaceuticals, Inc.

Industry: Medical - Drugs

Record: 23

03/02/2022

Daily Note

Pages: 4

We cordially invite you to attend a hosted fireside chat with Arrowhead’s President and CEO, to discuss the recent progress

Provider: H.C. Wainwright & Co., Inc.

Analyst: TRUCCHIO P

Price: 5.00

Research Provided by a Third Party

Company: Arrowhead Pharmaceuticals, Inc.

Industry: Medical - Drugs

Record: 24

02/08/2022

Company Report

Pages: 35

Potential Blockbuster CVD, Complement, and Partnered Programs on Track

Provider: H.C. Wainwright & Co., Inc.

Analyst: TRUCCHIO P

Price: 35.00

Research Provided by a Third Party

Company: Arrowhead Pharmaceuticals, Inc.

Industry: Medical - Drugs

Record: 25

12/15/2021

Company Report

Pages: 32

Leading RNAi TRiM Platform on Track to Generate Peak Annual Revenues of More Than $20B

Provider: H.C. Wainwright & Co., Inc.

Analyst: TRUCCHIO P

Price: 35.00

Research Provided by a Third Party

Company: Arrowhead Pharmaceuticals, Inc.

Industry: Medical - Drugs

Record: 26

09/28/2021

Company Report

Pages: 10

ValuEngine Detailed Valuation Report for ARWR

Provider: ValuEngine, Inc

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: Arrowhead Pharmaceuticals, Inc.

Industry: Medical - Drugs

Record: 27

08/10/2021

Company Report

Pages: 10

F3Q21 Results; Announces C3 Program; Enrollment in Key CVD Phase 2 Trials Underway; Upping PT to $100

Provider: H.C. Wainwright & Co., Inc.

Analyst: TRUCCHIO P

Price: 25.00

Research Provided by a Third Party

Company: Arrowhead Pharmaceuticals, Inc.

Industry: Medical - Drugs

Record: 28

07/02/2021

Company Report

Pages: 7

Sell-off Tied to ARO-EnAC Phase 1/2 Study Halt Is Overdone; Valuable Liver-Directed Programs on Track; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: TRUCCHIO P

Price: 25.00

Research Provided by a Third Party

Company: Arrowhead Pharmaceuticals, Inc.

Industry: Medical - Drugs

Record: 29

06/23/2021

Daily Note

Pages: 4

Generates Compelling Initial Data on Liver Fibrosis Target, With Positive Read-Through to ALNY program

Provider: H.C. Wainwright & Co., Inc.

Analyst: TRUCCHIO P

Price: 10.00

Research Provided by a Third Party

Company: Arrowhead Pharmaceuticals, Inc.

Industry: Medical - Drugs

Record: 30

05/07/2021

Company Report

Pages: 11

F2Q21 Results; On the Cusp of Validating RNAi Therapeutics Outside the Liver

Provider: H.C. Wainwright & Co., Inc.

Analyst: TRUCCHIO P

Price: 25.00

Research Provided by a Third Party

Company: Arrowhead Pharmaceuticals, Inc.

Industry: Medical - Drugs

Record: 31

02/05/2021

Company Report

Pages: 13

F1Q21 Results; Pipeline Advancing With Multiple Data Readouts on Track; Upping PT to $95; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: TRUCCHIO P

Price: 50.00

Research Provided by a Third Party

Company: Arrowhead Pharmaceuticals, Inc.

Industry: Medical - Drugs

Record: 32

12/01/2020

Company Report

Pages: 48

Strong Finish to Transformational Year; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: TRUCCHIO P

Price: 100.00

Research Provided by a Third Party

Company: Arrowhead Pharmaceuticals, Inc.

Industry: Medical - Drugs

Record: 33

10/30/2020

Industry Report

Pages: 58

HBV Mini-Conference Key Takeaways

Provider: H.C. Wainwright & Co., Inc.

Analyst: Research Department

Price: 100.00

Research Provided by a Third Party

Company: Arrowhead Pharmaceuticals, Inc.

Industry: Medical - Drugs

Record: 34

10/12/2020

Company Report

Pages: 13

Alpha One Collaboration Clears Way to Focus on High Value Cardio-Metabolic and Pulmonary Franchises

Provider: H.C. Wainwright & Co., Inc.

Analyst: TRUCCHIO P

Price: 50.00

Research Provided by a Third Party

Company: Arrowhead Pharmaceuticals, Inc.

Industry: Medical - Drugs

Record: 35

09/17/2020

Company Report

Pages: 33

Pipeline Is Firing on All Cylinders; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: Research Department

Price: 75.00

Research Provided by a Third Party

Company: Arrowhead Pharmaceuticals, Inc.

Industry: Medical - Drugs

Record: 36

08/26/2020

Industry Report

Pages: 9

EASL 2020 Virtual Meeting Overview and Planner

Provider: H.C. Wainwright & Co., Inc.

Analyst: ARCE E

Price: 25.00

Research Provided by a Third Party

Company: Arrowhead Pharmaceuticals, Inc.

Industry: Medical - Drugs

Record: 37

08/24/2020

Company Report

Pages: 103

Hitting the Bullseye in Multiple Tissues; Initiating With a Buy and $90 Price Target

Provider: H.C. Wainwright & Co., Inc.

Analyst: Research Department

Price: 150.00

Research Provided by a Third Party

Company: Arrowhead Pharmaceuticals, Inc.

Industry: Medical - Drugs

Record: 38

08/24/2020

Industry Report

Pages: 74

Biopharma''s Next $100B-Plus Global Market: Cures for Chronic Hepatitis B Virus Infection

Provider: H.C. Wainwright & Co., Inc.

Analyst: Research Department

Price: 150.00

Research Provided by a Third Party

Company: Arrowhead Pharmaceuticals, Inc.

Industry: Medical - Drugs

Record: 39

08/10/2020

Company Report

Pages: 8

Provider: Zacks Investment Research

Analyst: Research Department

Price: 24.95

Research Provided by a Third Party

Company: Arrowhead Pharmaceuticals, Inc.

Industry: Medical - Drugs

Record: 40

02/25/2020

Company Report

Pages: 13

Provider: Zacks Investment Research

Analyst: Research Department

Price: 24.95

Research Provided by a Third Party